The Biotech Growth Trust (BIOG) invests worldwide in the innovative area of biotechnology, with the aim of achieving capital growth. Biotech has been one of the strongest-performing market sectors in recent years, but controversy over drug pricing in the US caused a sell-off in September, denting returns over shorter periods. BIOG’s managers argue that truly innovative and effective new treatments will continue to have strong pricing power. The trust’s investment approach is catal
15 Dec 2015
Positioned for clinical success
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Positioned for clinical success
Biotech Growth Trust PLC (BIOG:LON) | 928 -102.1 (-1.2%) | Mkt Cap: 310.9m
- Published:
15 Dec 2015 - Author:
-
Pages:
8
The Biotech Growth Trust (BIOG) invests worldwide in the innovative area of biotechnology, with the aim of achieving capital growth. Biotech has been one of the strongest-performing market sectors in recent years, but controversy over drug pricing in the US caused a sell-off in September, denting returns over shorter periods. BIOG’s managers argue that truly innovative and effective new treatments will continue to have strong pricing power. The trust’s investment approach is catal